Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | Allograft rejection 💬 11 genes, 23 drugs (DrugBank) and 56 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
2 | Allograft rejection 💬 11 genes, 23 drugs (DrugBank) and 56 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
3 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
4 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
5 | Autoimmune thyroid disease 💬 22 genes, 15 drugs (DrugBank) and 35 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
6 | Autoimmune thyroid disease 💬 22 genes, 15 drugs (DrugBank) and 35 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
7 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
8 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
9 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL5RA [1] IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬
|
10 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
11 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
12 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
13 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
14 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
IL5RA [1] IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬
|
15 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
16 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
17 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
18 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
19 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
20 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
21 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
22 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
23 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL5RA [1] IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬
|
24 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
25 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
26 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL5RA [1] IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬
|
27 | T cell receptor signaling pathway 💬 34 genes, 46 drugs (DrugBank) and 80 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
28 | T cell receptor signaling pathway 💬 34 genes, 46 drugs (DrugBank) and 80 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
29 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
30 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|